By Sheeba M. | June 12, 2026
Tilray Surges on Q2 Cannabis Sales Growth Amid Industry Consolidation
Tilray Brands reported stronger-than-expected adjusted EBITDA margins in the second quarter, with the cannabis producer posting 18.2% profitability on $175.4 million in net revenue. The beat sent Tilray stock up 8.7% in after-hours trading as investors reappraised the company’s path to sustained profitability.
The margin expansion reflects two structural shifts in the cannabis market. First, consolidation among multistate operators (MSOs) has reduced competitive pricing pressure, allowing Tilray to maintain higher average selling prices (ASP) even as volumes grew 12% sequentially. Second, operational efficiencies from legacy Aphria integration and improved supply chain logistics are flowing through the P&L at scale.
The Profitability Inflection Point
Tilray’s Q2 adjusted EBITDA of $31.9 million marks the highest quarterly figure since the company’s 2021 merger. Management guided for adjusted EBITDA margins to expand further to 22-25% by end of fiscal 2026, which would position TLRY as the first MSO to achieve and sustain enterprise-level profitability metrics.
Notably, cash burn has turned positive. Free cash flow reached $12.3 million in Q2, a $18.5 million swing from Q1’s negative $6.2 million. This matters because it signals that cannabis operators are moving beyond the venture-backed burn model into self-sustaining businesses.
What the Street is Watching
Analysts are now focused on three key metrics for the remainder of 2026: (1) whether Tilray can maintain >17% adjusted EBITDA margins as supply competition intensifies in key states; (2) debt reduction progress (current net debt: $312 million); and (3) whether federal cannabis legalization could disrupt the pricing power that’s driving current margins.
Institutional investors are taking notice. Tilray’s institutional ownership increased 14 basis points in Q2 as hedge funds rotated into cannabis stocks perceived as undervalued relative to profitability inflection. The stock is now trading at a 4.2x forward EBITDA multiple—still a 35% discount to comparable consumer packaged goods companies.
Sources
- Tilray Investor Relations — Official Q2 2026 earnings release
- SEC EDGAR — 10-Q filing (TLRY)
- CNBC Markets — Cannabis sector profitability trends
Track cannabis stocks with the Weedstock Real-Time Tracker